"Niacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.
| Descriptor ID |
D009525
|
| MeSH Number(s) |
D03.066.515.475 D03.383.725.547.475
|
| Concept/Terms |
Niacin- Niacin
- Nicotinic Acid
- 3-Pyridinecarboxylic Acid
- 3 Pyridinecarboxylic Acid
|
Below are MeSH descriptors whose meaning is more general than "Niacin".
Below are MeSH descriptors whose meaning is more specific than "Niacin".
This graph shows the total number of publications written about "Niacin" by people in this website by year, and whether "Niacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Niacin" by people in Profiles.
-
Skolnik N, Jaffa FM, Kalyani RR, Johnson E, Shubrook JH. Reducing CV risk in diabetes: An ADA update. J Fam Pract. 2017 May; 66(5):300-308.
-
Gaynon MW, Paulus YM, Rahimy E, Alexander JL, Mansour SE. Effect of oral niacin on central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2017 Jun; 255(6):1085-1092.
-
Rahimy E, Gaynon MW, Paulus YM, Alexander JL, Mansour SE. Potentially Reversible Effect of Niacin Therapy on Edema From Retinal Vein Occlusion. JAMA Ophthalmol. 2016 07 01; 134(7):839-40.
-
Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P, Zhao XQ, Boden WE. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013 Oct 22; 62(17):1580-4.
-
Teo KK, Goldstein LB, Chaitman BR, Grant S, Weintraub WS, Anderson DC, Sila CA, Cruz-Flores S, Padley RJ, Kostuk WJ, Boden WE. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke. 2013 Oct; 44(10):2688-93.
-
Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011 Dec 15; 365(24):2255-67.
-
Tittler EH, de Barros DS, Navarro JB, Freitas DG, Gheith ME, Siam GA, Spaeth GL. Oral niacin can increase intraocular pressure. Ophthalmic Surg Lasers Imaging. 2008 Jul-Aug; 39(4):341-2.
-
Codario RA. Hypertriglyceridemia and cardiovascular disease management. J Am Acad Nurse Pract. 2007; 19(12 Suppl 2):7-10, 13-4.
-
Capuzzi DM, Morgan JM, Carey CM, Intenzo C, Tulenko T, Kearney D, Walker K, Cressman MD. Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia. Prev Cardiol. 2004; 7(4):176-81.
-
Morgan JM, Capuzzi DM, Baksh RI, Intenzo C, Carey CM, Reese D, Walker K. Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol. 2003 Jun 15; 91(12):1432-6.